Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

January 11, 2021January 11, 2021

Clinical Benefits of ABX464 for Ulcerative Colitis Revealed in Review Study

IBD News, News, Ulcerative colitis

Abivax has published a review study summarizing the mechanisms, as well as the previously undisclosed clinical benefits of ABX464, its treatment candidate for people with inflammatory diseases, including ulcerative ... Read more

December 21, 2020December 21, 2020

Abivax Completes Enrollment in ABX464 Trial for Ulcerative Colitis

News, Ulcerative colitis

Abivax has completed patient enrollment, ahead of schedule and despite the COVID 19 pandemic, in its Phase 2b trial evaluating ABX464 as a treatment candidate for people with moderate-to-severe ... Read more

November 2, 2020November 2, 2020

Rare Microscopic Colitis in IBD Associated With More Active Inflammation, Study Reports

News

Lymphocytic colitis (LC) and collagenous colitis (CC) occur rarely in people with inflammatory bowel disease (IBD) but are linked with more active inflammation, a study reports. The findings highlight the ... Read more

April 20, 2020April 20, 2020

New Guidelines Issued on Treating IBD Patients During COVID-19 Pandemic

News

Leading experts have drafted new guidelines to aid gastroenterologists in the management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic, according to an American Gastroenterological Association (AGA) ... Read more

March 30, 2020March 30, 2020

Gut Bacteria Adapt Their Behavior Depending on Where They Reside, Mouse Study Suggests

News

Bacteroides fragilis, bacteria known for their protective role in the gut, change their gene activity and behavior according to where in the gut they reside, a study in mice ... Read more

March 13, 2020March 13, 2020

Inflammation Type Linked to Flares, Hospitalizations in IBD Patients, Study Says

News

People with inflammatory bowel disease (IBD) whose gut inflammation is driven by eosinophils — a type of white blood cells — are less likely to experience disease flares and ... Read more

March 2, 2020March 2, 2020

Remsima in New Injection Form Shows Safety and Efficacy in Trial

News

A new formulation of CT-P13, a biosimilar of Remicade (infliximab), given as an under-the-skin injection is as safe and effective for people with active Crohn’s disease (CD) and ulcerative colitis (UC) ... Read more

February 7, 2020February 7, 2020

Probiotic Patch Enhances Intestinal Wound Healing in IBD, Mouse Study Shows

News

A probiotic-based therapeutic approach, where gut bacteria were genetically engineered to produce a patch, enhanced intestinal wound healing in a mouse model of inflammatory bowel disease (IBD), a study ... Read more

February 5, 2020February 5, 2020

Study Links Mediterranean Diet to Lower Risk of Late-onset Crohn’s Disease

News

Adhering to a Mediterranean diet lowers the risk of developing Crohn’s disease in middle age, a large Swedish study reports. The study, “Adherence to a Mediterranean diet is associated with ... Read more

February 3, 2020February 3, 2020

Study Identifies Risk Factors for the Poor Sleep Experienced by Two-thirds of IBD Patients

News

Researchers have identified risk factors — greater disability, lower quality of life, and non-intestinal symptoms — for the poor sleep experienced by two-thirds of patients with inflammatory bowel disease ... Read more